• Thu, January 3, 2013

by: WOPRAI

Medex Inc (OTC:MDXX), Down By 93.33% ($0.03) From $0.030 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish C

by: WOPRAI

FutureFuel Corp (NYSE:FF), Up By 5.24% ($0.62) From $11.840 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish

by: WOPRAI

Gramercy Capital Corp (NYSE:GKK), Up By 6.12% ($0.18) From $2.940 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bu

by: WOPRAI

Republic Airways Holdings Inc (NASDAQ:RJET), Up By 15.39% ($0.92) After BUYINS.NET SqueezeTrigger Report Released on Wednesday,

by: WOPRAI

FRAN SqueezeTrigger Price is $26.75. There is $306,812,888 That Short Sellers Still Need To Cover.

by: WOPRAI

DRH SqueezeTrigger Price is $9.27. There is $87,104,720 That Short Sellers Still Need To Cover.

by: WOPRAI

MNRO SqueezeTrigger Price is $35.60. There is $204,822,016 That Short Sellers Still Need To Cover.

by: WOPRAI

ROST SqueezeTrigger Price is $57.05. There is $263,086,560 That Short Sellers Still Need To Cover.

by: WOPRAI

EOC SqueezeTrigger Price is $49.37. There is $11,806,600 That Short Sellers Still Need To Cover.

by: WOPRAI

MCY SqueezeTrigger Price is $40.65. There is $22,882,500 That Short Sellers Still Need To Cover.

by: WOPRAI

TBIO, Removed From Naked Short Lists Today

by: WOPRAI

CYCC, Has Remained On Naked Short Lists 13 Consecutive Days

by: WOPRAI

HRTPY, Added To Naked Short Lists Today

by: WOPRAI

LKFN, CKEC, Expected to Trade Higher After Bullish Insider Trading

by: WOPRAI

Alcatel Lucent SA (NYSE:ALU), Down By 30.00% ($0.42) From $1.400 After BUYINS.NET Report Predicted Stock Would Go Down Due To B

by: WOPRAI

VIG, SA, PRKR Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

FXE, TRMK, STFC, RGC, CTRP, BCA Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

DEF, TWC, FDL, BMTI, DHS, SATS Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

GBNK, TAT, GRO, VEA, AXU, KALU Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

RBS, ITM Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

CRDC, CBLI, DUA, GLDD, SIRO, VRTU Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

DMLP, GRH, BBNK, SIMO, ZUMZ, CTCT Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

DLR, AMSWA, WLL, GLD, KTP, HOFT Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

SNMX, AHT, VIA, HURC, DFS, WMAR Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

WWW, FAST, IBCA Expected To Be Up Before Next Earnings Releases

by: WOPRAI

TLAB, CRRC, SYBT Expected To Be Down Before Next Earnings Releases

by: WOPRAI

Blayne Curtis Downgraded (AMD) to Sell and Held Target at $2 on, Jan 3rd, 2013

by: WOPRAI

PJ Juvekar Maintained (APD) at Hold with Increased Target to $91 on, Jan 3rd, 2013

by: WOPRAI

Tycho Peterson Downgraded (WAT) to Hold and Held Target at $90 on, Jan 3rd, 2013

by: WOPRAI

Steve Beuchaw Downgraded (WAT) to Hold on, Jan 3rd, 2013

by: WOPRAI

Steven Chubak Maintained (C) at Strong Buy with Increased Target to $45 on, Jan 3rd, 2013

by: WOPRAI

Lana Chan Downgraded (CATY) to Hold and Held Target at $21 on, Jan 3rd, 2013

by: WOPRAI

Christopher Raymond Downgraded (BIIB) to Hold and Decreased Target to $166 on, Jan 3rd, 2013

by: WOPRAI

Jay Olson Maintained (BIIB) at Hold with Decreased Target to $141 on, Jan 3rd, 2013

by: WOPRAI

Sumant Kulkarni Maintained (BIIB) at Hold with Decreased Target to $139 on, Jan 3rd, 2013

by: WOPRAI

David Lewis Upgraded (BDX) to Hold on, Jan 3rd, 2013

by: WOPRAI

Nathan Jones Maintained (VMI) at Strong Buy with Increased Target to $161 on, Jan 3rd, 2013

by: WOPRAI

PJ Juvekar Maintained (CE) at Strong Buy with Increased Target to $54 on, Jan 3rd, 2013

by: WOPRAI

Blayne Curtis Maintained (CRUS) at Buy with Decreased Target to $36 on, Jan 3rd, 2013

by: WOPRAI

Jay Gelb Maintained (AON) at Hold with Increased Target to $55 on, Jan 3rd, 2013

by: WOPRAI

Blayne Curtis Maintained (TXN) at Hold with Increased Target to $30 on, Jan 3rd, 2013

by: WOPRAI

Blayne Curtis Maintained (ADI) at Hold with Increased Target to $45 on, Jan 3rd, 2013

by: WOPRAI

Jimmy Bhullar Downgraded (AFL) to Hold and Decreased Target to $27 on, Jan 3rd, 2013

by: WOPRAI

Jay Gelb Maintained (AFL) at Buy with Increased Target to $33 on, Jan 3rd, 2013

by: WOPRAI

Steven Chubak Maintained (BAC) at Hold with Increased Target to $11 on, Jan 3rd, 2013

by: WOPRAI

Keith Horowitz Maintained (BAC) at Hold with Increased Target to $12 on, Jan 3rd, 2013

by: WOPRAI

Mark Schappel Maintained (AZPN) at Strong Buy with Increased Target to $33 on, Jan 3rd, 2013

by: WOPRAI

PJ Juvekar Maintained (ALB) at Strong Buy with Increased Target to $74 on, Jan 3rd, 2013

Sumant Kulkarni Maintained (BIIB) at Hold with Decreased Target to $139 on, Jan 3rd, 2013

Sumant Kulkarni of Canaccord Genuity, Maintained "Biogen Inc." (BIIB) at Hold with Decreased Target from $144 to $139 on, Jan 3rd, 2013.

Sumant has made no other calls on BIIB in the last 4 months.



There are 2 other peers that have a rating on BIIB. Out of the 2 peers that are also analyzing BIIB, 0 agree with Sumant's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Sumant

  • Evan Seigerman of "Credit Suisse" Maintained at Buy with Increased Target to $175 on, Monday, October 8th, 2012
  • Andrew Peters of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $160 on, Thursday, September 6th, 2012